Cargando…

A PRACTICAL GUIDE TO OPTIMIZING THE BENEFITS OF POST-STROKE SPASTICITY INTERVENTIONS WITH BOTULINUM TOXIN A: AN INTERNATIONAL GROUP CONSENSUS

This consensus paper is derived from a meeting of an international group of 19 neurological rehabilitation specialists with a combined experience of more than 250 years (range 4–25 years; mean 14.1 years) in treating post-stroke spasticity with botulinum toxin A. The group undertook critical assessm...

Descripción completa

Detalles Bibliográficos
Autores principales:	FRANCISCO, Gerard E., BALBERT, Alexander, BAVIKATTE, Ganesh, BENSMAIL, Djamel, CARDA, Stefano, DELTOMBE, Thierry, DRAULANS, Nathalie, ESCALDI, Steven, GROSS, Raphaël, JACINTO, Jorge, KETCHUM, Nicholas, MOLTENI, Franco, MORALEDA, Susana, O’DELL, Michael W., REEBYE, Rajiv, SÄTERÖ, Patrik, VERDUZCO-GUTIERREZ, Monica, WALKER, Heather, WISSEL, Jörg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Foundation for Rehabilitation Information 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772370/ https://www.ncbi.nlm.nih.gov/pubmed/33057730 http://dx.doi.org/10.2340/16501977-2753

Ejemplares similares

The role of physical and rehabilitation medicine in the COVID-19 pandemic: The clinician's view
por: Carda, Stefano, et al.
Publicado: (2020)

Botulinum Toxin Services for Neurorehabiliation: Recommendations for Challenges and Opportunities during the COVID-19 Pandemic
por: Bavikatte, Ganesh, et al.
Publicado: (2021)

Ergonomic Recommendations in Ultrasound-Guided Botulinum Neurotoxin Chemodenervation for Spasticity: An International Expert Group Opinion
por: Lagnau, Philippe, et al.
Publicado: (2021)

A practical guide to botulinum neurotoxin treatment of shoulder spasticity 1: Anatomy, physiology, and goal setting
por: Jacinto, Jorge, et al.
Publicado: (2022)

A practical guide to botulinum neurotoxin treatment of shoulder spasticity 2: Injection techniques, outcome measurement scales, and case studies
por: Wissel, Jörg, et al.
Publicado: (2022)

EUROPEAN EXPERT CONSENSUS ON IMPROVING PATIENT SELECTION FOR THE MANAGEMENT OF DISABLING SPASTICITY WITH INTRATHECAL BACLOFEN AND/OR BOTULINUM TOXIN TYPE A
por: BIERING-SØRENSEN, Bo, et al.
Publicado: (2021)

Perioperative Botulinum Toxin Injections to Enhance Surgical Outcomes in Patients With Spasticity: Preoperative, Intraoperative, and Postoperative Case Reports
por: Frost, Geoffrey, et al.
Publicado: (2021)

Canadian Physicians' Use of Perioperative Botulinum Toxin Injections to Spastic Limbs: A Cross-sectional National Survey
por: Kassam, Farris, et al.
Publicado: (2021)

Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study
por: Wissel, Jörg, et al.
Publicado: (2017)

Botulinum toxin use in patients with post-stroke spasticity: a nationwide retrospective study from France
por: Levy, Jonathan, et al.
Publicado: (2023)

Canadian Physicians’ Use of Intramuscular Botulinum Toxin Injections for Shoulder Spasticity: A National Cross-Sectional Survey
por: Kassam, Farris, et al.
Publicado: (2023)

Goal-Setting in Multiple Sclerosis-Related Spasticity Treated with Botulinum Toxin: The GASEPTOX Study
por: Baccouche, Ines, et al.
Publicado: (2022)

WORLDWIDE SURVEY OF CLINICIAN PRACTICE ON USE OF ADJUNCTIVE THERAPIES FOLLOWING BOTULINUM TOXIN INJECTION FOR SPASTICITY
por: SCHILLEBEECKX, Fabienne, et al.
Publicado: (2022)

The Effects of Botulinum Toxin Injections on Spasticity and Motor Performance in Chronic Stroke with Spastic Hemiplegia
por: Chen, Yen-Ting, et al.
Publicado: (2020)

Post-Stroke Spastic Movement Disorder and Botulinum Toxin A Therapy: Early Detection And Early Injection
por: Wissel, Jörg, et al.
Publicado: (2023)

Early Identification, Intervention and Management of Post-stroke Spasticity: Expert Consensus Recommendations
por: Bavikatte, Ganesh, et al.
Publicado: (2021)

Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA
por: Fheodoroff, Klemens, et al.
Publicado: (2020)

Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity
por: Jacinto, Jorge, et al.
Publicado: (2020)

Therapy of Sialorrhea with Botulinum Neurotoxin
por: Jost, Wolfgang H., et al.
Publicado: (2019)

Corrigendum: Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity
por: Jacinto, Jorge, et al.
Publicado: (2020)

EFFECTS OF DIAGNOSTIC TIBIAL NERVE BLOCK AND SELECTIVE TIBIAL NERVE NEUROTOMY ON SPASTICITY AND SPASTIC CO-CONTRACTIONS: A RETROSPECTIVE OBSERVATIONAL STUDY
por: LAMORA, Jean-Philippe, et al.
Publicado: (2023)

Cryoneurotomy as a Percutaneous Mini-invasive Therapy for the Treatment of the Spastic Limb: Case Presentation, Review of the Literature, and Proposed Approach for Use
por: Winston, Paul, et al.
Publicado: (2019)

The Central Effects of Botulinum Toxin in Dystonia and Spasticity
por: Hok, Pavel, et al.
Publicado: (2021)

Trends in Botulinum Toxin Use among Patients with Multiple Sclerosis: A Population-Based Study
por: Bensmail, Djamel, et al.
Publicado: (2023)

Reliability and Validity of the Modified Heckmatt Scale in Evaluating Muscle Changes With Ultrasound in Spasticity
por: Moreta, Marisa C., et al.
Publicado: (2020)

Guidelines for the use of botulinum toxin in movement disorders and spasticity
por: Jabeen, Afshan, et al.
Publicado: (2011)

Experiences of patients with poststroke spasticity throughout a botulinum toxin treatment cycle: Results from a prospective ethnographic study
por: Jacinto, Jorge, et al.
Publicado: (2022)

Botulinum Toxin Treatment for Limb Spasticity in Childhood Cerebral Palsy
por: Pavone, Vito, et al.
Publicado: (2016)

Effect of botulinum toxin type-A in patients with focal spasticity
por: Selimoglu, Esra, et al.
Publicado: (2015)

Spasticity treatment with botulinum toxin during the COVID-19 pandemic
por: Branquinho, Lurdes Rovisco, et al.
Publicado: (2021)

Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple Sclerosis
por: Novarella, Federica, et al.
Publicado: (2022)

Effect of botulinum toxin injection on length and force of the rectus femoris and triceps surae muscles during locomotion in patients with chronic hemiparesis (FOLOTOX)
por: Supiot, Anthony, et al.
Publicado: (2018)

The Effect of Repeated abobotulinumtoxinA (Dysport®) Injections on Walking Velocity in Persons with Spastic Hemiparesis Caused by Stroke or Traumatic Brain Injury
por: Esquenazi, Alberto, et al.
Publicado: (2020)

High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study
por: Francisco, Gerard E., et al.
Publicado: (2020)

EARLY BRAIN IMAGING PREDICTORS OF POST-STROKE SPASTICITY
por: RI, Songjin, et al.
Publicado: (2021)

The Lack of Systemic and Subclinical Side Effects of Botulinum Neurotoxin Type-A in Patients Affected by Post-Stroke Spasticity: A Longitudinal Cohort Study
por: Battaglia, Marco, et al.
Publicado: (2022)

LONGITUDINAL GOAL ATTAINMENT WITH INTEGRATED UPPER LIMB SPASTICITY MANAGEMENT INCLUDING REPEAT INJECTIONS OF BOTULINUM TOXIN A: FINDINGS FROM THE PROSPECTIVE, OBSERVATIONAL UPPER LIMB INTERNATIONAL SPASTICITY (ULIS-III) COHORT STUDY
por: TURNER-STOKES, Lynne, et al.
Publicado: (2021)

Botulinum Neurotoxin-A Injection in Adult Cervical Dystonia and Spastic Paresis: Results From the INPUT (INjection Practice, Usage and Training) Survey
por: Chung, Tae Mo, et al.
Publicado: (2020)

Serotonin Syndrome Mimicking Intrathecal Baclofen Withdrawal in a Patient with Hereditary Spastic Paraparesis
por: Goffin, Nicolas, et al.
Publicado: (2020)

CLINICAL PRESENTATION OF PATIENTS WITH LOWER LIMB SPASTICITY UNDER-GOING ROUTINE TREATMENT WITH BOTULINUM TOXIN: BASELINE FINDINGS FROM AN INTERNATIONAL OBSERVATIONAL STUDY
por: ESQUENAZI, Alberto, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d96sjear4u07ug95nd1g8sbgta